𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anticancer drugs: Targeting triple-negative breast cancer

✍ Scribed by Kirkpatrick, Peter

Book ID
109950729
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
277 KB
Volume
8
Category
Article
ISSN
1474-1776

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Triple-negative breast cancer
Triple-negative breast cancer
✍ Rupert Bartsch; Reinhard Ziebermayr; Christoph C. Zielinski; Guenther G. Steger πŸ“‚ Article πŸ“… 2010 πŸ› Springer Vienna 🌐 German βš– 165 KB
Triple Negative Breast Cancer
Triple Negative Breast Cancer
✍ S. Ressler; B. Mlineritsch; R. Greil πŸ“‚ Article πŸ“… 2010 πŸ› Springer-Verlag 🌐 English βš– 193 KB
Characteristics of triple-negative breas
Characteristics of triple-negative breast cancer
✍ Tim C. de Ruijter; JΓΌrgen Veeck; Joep P. J. de Hoon; Manon van Engeland; Viviann πŸ“‚ Article πŸ“… 2010 πŸ› Springer-Verlag 🌐 English βš– 254 KB

## Background Triple-negative breast cancers (TNBC) neither express hormone receptors, nor overexpress HER2. They are associated with poor prognosis, as defined by low five-year survival and high recurrence rates after adjuvant therapy. Overall, TNBC share striking similarities with basal-like brea

Prognostic markers in triple-negative br
Prognostic markers in triple-negative breast cancer
✍ Emad A. Rakha; Maysa E. El-Sayed; Andrew R. Green; Andrew H. S. Lee; John F. Rob πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 157 KB
How basal are triple-negative breast can
How basal are triple-negative breast cancers?
✍ FranΓ§ois Bertucci; Pascal Finetti; Nathalie Cervera; Benjamin Esterni; Fabienne πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 99 KB

## Abstract The basal molecular subtype of breast cancer (BC) is defined by the mRNA expression pattern of an intrinsic ∼500‐gene set. It is the most homogeneous subtype in transcriptional terms, and one of the most aggressive in prognostic terms. Clinical trials testing new systemic therapeutic st